A new innovation fund will accelerate translational oncology research at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. Carefully designed to advance faculty-led projects, the Sylvester Innovates Fund (SIF) will provide up to $1 million for promising cancer discoveries and inventions with clinical potential.
“Our Sylvester Innovates Fund—Biomedical Competition is designed to accelerate the translation of promising cancer research into clinical and commercial applications,” said Stephen D. Nimer, M.D., Sylvester director, Oscar de la Renta Endowed Chair in Cancer Research, executive dean for research and professor of medicine, biochemistry and molecular biology at the Miller School. “In fostering a culture of innovation and entrepreneurial thinking, the initiative highlights Sylvester’s research talent, attracting interest from investors, biotech and pharmaceutical partners and creating opportunities for collaboration, licensing and long-term impact.”
Full story: Sylvester Innovates Accelerates Early-Stage Cancer Discoveries and Inventions – InventUM
